Molecular Pathogenesis of Middle East Respiratory Syndrome (MERS) Coronavirus

被引:12
作者
Banerjee, Arinjay [1 ]
Bald, Kaushal [2 ]
Mossman, Karen [1 ,2 ]
机构
[1] McMaster Univ, McMaster Immunol Res Ctr, Michael DeGroote Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada
[2] McMaster Univ, McMaster Immunol Res Ctr, Michael DeGroote Inst Infect Dis Res, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
MERS; Coronavirus; Pathogenesis; Therapeutics; RNA-BINDING PROTEIN; FUNCTIONAL RECEPTOR; RIG-I; SARS; COV; BATS; 4A; PHOSPHORYLATION; RECOMBINATION; REPLICATION;
D O I
10.1007/s40588-019-00122-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Purpose of Review Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012 and is listed in the World Health Organization's blueprint of priority diseases that need immediate research. Camels are reservoirs of this virus, and the virus spills over into humans through direct contact with camels. Human-to-human transmission and travel-associated cases have been identified as well. Limited studies have characterized the molecular pathogenesis of MERS-CoV. Most studies have used ectopic expression of viral proteins to characterize MERS-CoV and its ability to modulate antiviral responses in human cells. Studies with live virus are limited, largely due to the requirement of high containment laboratories. In this review, we have summarized current studies on MERS-CoV molecular pathogenesis and have mentioned some recent strategies that are being developed to control MERS-CoV infection. Recent Findings Multiple antiviral molecules with the potential to inhibit MERS-CoV infection by disrupting virus-receptor interactions are being developed and tested. Although human vaccine candidates are still being developed, a candidate camel vaccine is being tested for efficacy. Combination of supportive treatment with interferon and antivirals is also being explored. New antiviral molecules that inhibit MERS-CoV and host cell receptor interaction may become available in the future. Additional studies are required to identify and characterize the pathogenesis of MERS-CoV EMC/2012 and other circulating strains. An effective MERS-CoV vaccine, for humans and/or camels, along with an efficient combination antiviral therapy may help us prevent future MERS cases.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 61 条
[1]   Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas [J].
Adney, Danielle R. ;
Wang, Lingshu ;
van Doremalen, Neeltje ;
Shi, Wei ;
Zhang, Yi ;
Kong, Wing-Pui ;
Miller, Megan R. ;
Bushmaker, Trenton ;
Scott, Dana ;
de Wit, Emmie ;
Modjarrad, Kayvon ;
Petrovsky, Nikolai ;
Graham, Barney S. ;
Bowen, Richard A. ;
Munster, Vincent J. .
VIRUSES-BASEL, 2019, 11 (03)
[2]   Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Perpetual Challenge [J].
Al Hajjar, Sami ;
Memish, Ziad A. ;
McIntosh, Kenneth .
ANNALS OF SAUDI MEDICINE, 2013, 33 (05) :427-436
[3]   Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study [J].
Al-Tawfiq, Jaffar A. ;
Momattin, Hisham ;
Dib, Jean ;
Memish, Ziad A. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 20 :42-46
[4]  
[Anonymous], VIRUSES BASEL
[5]  
Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]
[6]   Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial [J].
Arabi, Yaseen M. ;
Alothman, Adel ;
Balkhy, Hanan H. ;
Al-Dawood, Abdulaziz ;
AlJohani, Sameera ;
Al Harbi, Shmeylan ;
Kojan, Suleiman ;
Al Jeraisy, Majed ;
Deeb, Ahmad M. ;
Assiri, Abdullah M. ;
Al-Hameed, Fahad ;
AlSaedi, Asim ;
Mandourah, Yasser ;
Almekhlafi, Ghaleb A. ;
Sherbeeni, Nisreen Murad ;
Elzein, Fatehi Elnour ;
Memon, Javed ;
Taha, Yusri ;
Almotairi, Abdullah ;
Maghrabi, Khalid A. ;
Qushmaq, Ismael ;
Al Bshabshe, Ali ;
Kharaba, Ayman ;
Shalhoub, Sarah ;
Jose, Jesna ;
Fowler, Robert A. ;
Hayden, Frederick G. ;
Hussein, Mohamed A. .
TRIALS, 2018, 19
[7]   Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus [J].
Assiri, Abdullah ;
McGeer, Allison ;
Perl, Trish M. ;
Price, Connie S. ;
Al Rabeeah, Abdullah A. ;
Cummings, Derek A. T. ;
Alabdullatif, Zaki N. ;
Assad, Maher ;
Almulhim, Abdulmohsen ;
Makhdoom, Hatem ;
Madani, Hossam ;
Alhakeem, Rafat ;
Al-Tawfiq, Jaffar A. ;
Cotten, Matthew ;
Watson, Simon J. ;
Kellam, Paul ;
Zumla, Alimuddin I. ;
Memish, Ziad A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05) :407-416
[8]  
BANERJEE A, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11020152
[9]   A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response [J].
Bolles, Meagan ;
Deming, Damon ;
Long, Kristin ;
Agnihothram, Sudhakar ;
Whitmore, Alan ;
Ferris, Martin ;
Funkhouser, William ;
Gralinski, Lisa ;
Totura, Allison ;
Heise, Mark ;
Baric, Ralph S. .
JOURNAL OF VIROLOGY, 2011, 85 (23) :12201-12215
[10]   Middle East Respiratory Syndrome Coronavirus Quasispecies That Include Homologues of Human Isolates Revealed through Whole-Genome Analysis and Virus Cultured from Dromedary Camels in Saudi Arabia [J].
Briese, Thomas ;
Mishra, Nischay ;
Jain, Komal ;
Zalmout, Iyad S. ;
Jabado, Omar J. ;
Karesh, William B. ;
Daszak, Peter ;
Mohammed, Osama B. ;
Alagaili, Abdulaziz N. ;
Lipkin, W. Ian .
MBIO, 2014, 5 (03)